Figure 2

![Figure 2: Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population.]()

> Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." *Antibiotics (Basel, Switzerland)*, 2015. PMID: [27025619](https://pubmed.ncbi.nlm.nih.gov/27025619/)

<figure>
  <img src="" alt="Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population." />
  <figcaption>Figure 2. Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population.<br>  Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." <em>Antibiotics (Basel, Switzerland)</em>, 2015. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27025619/">27025619</a></figcaption>
</figure>